Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder

Journal of Psychiatric Research

Volumn 49, Issue 1, 2014, Pages 60-67

  Ramos Quiroga, Josep Antoni ^a,b,c   Sánchez Mora, Cristina ^a,b,d   Casas, Miguel ^a,b,c   Garcia Martínez, Iris ^a,d   Bosch, Rosa ^a,b   Nogueira, Mariana ^a   Corrales, Montse ^a   Palomar, Gloria ^a   Vidal, Raquel ^a   Coll Tané, Mireia ^a,d   Bayés, Mònica ^e   Cormand, Bru ^f,g   Ribasés, Marta ^a,b,d  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e Climate Research Laboratory Parc Cientific de Barcelona   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Attention deficit and hyperactivity disorder (ADHD); Autism; Copy number variation (CNV); Schizophrenia

Indexed keywords

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE DUPLICATION; GENE INSERTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OVERLAPPING GENE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ATTENTION-DEFICIT AND HYPERACTIVITY DISORDER (ADHD); AUTISM; COPY NUMBER VARIATION (CNV); SCHIZOPHRENIA;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHROMOSOME ABERRATIONS; COHORT STUDIES; DEVELOPMENTAL DISABILITIES; DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84891073803     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.10.022     Document Type: Article

References (72)

1. Antle M.C., van Diepen H.C., Deboer T., Pedram P., Pereira R.R., Meijer J.H. Methylphenidate modifies the motion of the circadian clock. Neuropsychopharmacology 2012, 37:2446-2455.
2. Baird A.L., Coogan A.N., Kaufling J., Barrot M., Thome J. Daily methylphenidate and atomoxetine treatment impacts on clock gene protein expression in the mouse brain. Brain Res 2013, 1513:61-71.
3. Baird A.L., Coogan A.N., Siddiqui A., Donev R.M., Thome J. Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels. Mol Psychiatry 2012, 17:988-995.
4. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005, 57:1215-1220.
5. Biederman J., Faraone S., Milberger S., Curtis S., Chen L., Marrs A., et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. JAm Acad Child Adolesc Psychiatry 1996, 35:343-351.
6. Biederman J., Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 2005, 366:237-248.
7. Biederman J., Faraone S.V., Mick E., Spencer T., Wilens T., Kiely K., et al. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. Am J Psychiatry 1995, 152:431-435.
8. Biederman J., Mick E., Faraone S.V. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000, 157:816-818.
9. Boomsma D.I., Saviouk V., Hottenga J.J., Distel M.A., de Moor M.H., Vink J.M., et al. Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults. PLoS One 2010, 12(5):e10621.
10. Bouwknecht J.A., Hijzen T.H., van der Gugten J., Maes R.A., Hen R., Olivier B. Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice. Biol Psychiatry 2001, 49:557-568.
11. Bradley W.E., Raelson J.V., Dubois D.Y., Godin E., Fournier H., Prive C., et al. Hotspots of large rare deletions in the human genome. PLoS One 2010, 5:e9401.
12. Brunner D., Buhot M.C., Hen R., Hofer M. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behaval Neurosci 1999, 113:587-601.
13. Caylak E. Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2012, 159B:613-627.
14. Coe B.P., Girirajan S., Eichler E.E. The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet C Semin Med Genet 2012, 160C:118-129.
15. Cooper G.M., Coe B.P., Girirajan S., Rosenfeld J.A., Vu T.H., Baker C., et al. Acopy number variation morbidity map of developmental delay. Nat Genet 2011, 43:838-846.
16. DeYoung CG, Getchell M, Koposov RA, Yrigollen CM, Haeffel GJ, af Klinteberg B, etal. Variation in the catechol-O-methyltransferase Val 158 Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents. Psychiatr Genet; 20:20-24.
17. Elia J., Gai X., Xie H.M., Perin J.C., Geiger E., Glessner J.T., et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010, 15:637-646.
18. Elia J., Glessner J.T., Wang K., Takahashi N., Shtir C.J., Hadley D., et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 2011, 44:78-84.
19. Faraone S., Biederman J., Monuteaux M.C. Further evidence for the diagnostic continuity between child and adolescent ADHD. JAtten Disord 2002, 6:5-13.
20. Faraone S.V., Biederman J., Feighner J.A., Monuteaux M.C. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more validα. JConsult Clin Psychol 2000, 68:830-842.
21. Faraone S.V., Biederman J., Monuteaux M.C. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemiol 2000, 18:1-16.
22. Faraone S.V., Biederman J., Spencer T., Wilens T., Seidman L.J., Mick E., et al. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000, 48:9-20.
23. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1313-1323.
24. Fliers E.A., Vasquez A.A., Poelmans G., Rommelse N., Altink M., Buschgens C., et al. Genome-wide association study of motor coordination problems in ADHD identifies genes for brain and muscle function. World J Biol Psychiatry 2012, 13:211-222.
25. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009, 126:51-90.
26. Hart E.L., Lahey B.B., Loeber R., Applegate B., Frick P.J. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. JAbnorm Child Psychol 1995, 23:729-749.
27. Hinney A., Scherag A., Jarick I., Albayrak O., Putter C., Pechlivanis S., et al. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:888-897.
28. Jacobsen K.K., Halmoy A., Sanchez-Mora C., Ramos-Quiroga J.A., Cormand B., Haavik J., et al. DISC1 in adult ADHD patients: an association study in two European samples. Am J Med Genet B Neuropsychiatr Genet 2013, 162B:227-234.
29. Jarick I., Volckmar A.L., Putter C., Pechlivanis S., Nguyen T.T., Dauvermann M.R., et al. Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder. Mol Psychiatry 2012.
30. Kan K.J., Dolan C.V., Nivard M.G., Middeldorp C.M., van Beijsterveldt C.E., Willemsen G., et al. Genetic and environmental stability in attention problems across the lifespan: evidence from the Netherlands twin register. JAm Acad Child Adolesc Psychiatry 2013, 52:12-25.
31. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006, 163:716-723.
32. Kirov G., Gumus D., Chen W., Norton N., Georgieva L., Sari M., et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 2008, 17:458-465.
33. Kuntsi J., Rijsdijk F., Ronald A., Asherson P., Plomin R. Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biol Psychiatry 2005, 57:647-654.
34. Langley K., Martin J., Agha S.S., Davies C., Stergiakouli E., Holmans P., et al. Clinical and cognitive characteristics of children with attention-deficit hyperactivity disorder, with and without copy number variants. Br J Psychiatry 2011, 199:398-403.
35. Lantieri F., Glessner J.T., Hakonarson H., Elia J., Devoto M. Analysis of GWAS top hits in ADHD suggests association to two polymorphisms located in genes expressed in the cerebellum. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:1127-1133.
36. Larsson H., Asherson P., Chang Z., Ljung T., Friedrichs B., Larsson J.O., et al. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins. Psychol Med 2013, 43:197-207.
37. Lasky-Su J., Anney R.J., Neale B.M., Franke B., Zhou K., Maller J.B., et al. Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1355-1358.
38. Lasky-Su J., Neale B.M., Franke B., Anney R.J., Zhou K., Maller J.B., et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1345-1354.
39. Lesch K.P., Selch S., Renner T.J., Jacob C., Nguyen T.T., Hahn T., et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry 2012, 16:491-503.
40. Lionel A.C., Crosbie J., Barbosa N., Goodale T., Thiruvahindrapuram B., Rickaby J., et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med 2011, 3:95ra75.
41. Malhotra D., McCarthy S., Michaelson J.J., Vacic V., Burdick K.E., Yoon S., et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011, 72:951-963.
42. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
43. Mick, E, Todorov A, Smalley S, Hu X, Loo S, Todd RD, etal. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry; 49:898-905 e3.
44. Molina-Carballo A., Naranjo-Gomez A., Uberos J., Justicia-Martinez F., Ruiz-Ramos M.J., Cubero-Millan I., et al. Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD. JPsychiatr Res 2013, 47:377-383.
45. Neale B.M., Lasky-Su J., Anney R., Franke B., Zhou K., Maller J.B., et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1337-1344.
46. Neale B.M., Medland S.E., Ripke S., Asherson P., Franke B., Lesch K.P., et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. JAm Acad Child Adolesc Psychiatry 2010, 49:884-897.
47. Palmason H., Moser D., Sigmund J., Vogler C., Hanig S., Schneider A., et al. Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant. JNeural Transm 2010, 117:259-267.
48. Poelmans G., Pauls D.L., Buitelaar J.K., Franke B. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. Am J Psychiatry 2011, 168:365-377.
49. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007, 164:942-948.
50. Polanczyk G., Rohde L.A. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry 2007, 20:386-392.
51. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
52. Ramboz S., Saudou F., Amara D.A., Belzung C., Segu L., Misslin R., et al. 5-HT1B receptor knock out-behavioral consequences. Behav Brain Res 1996, 73:305-312.
53. Ribases M., Hervas A., Ramos-Quiroga J.A., Bosch R., Bielsa A., Gastaminza X., et al. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 2008, 63:935-945.
54. Ribases M., Bosch R., Hervas A., Ramos-Quiroga J.A., Sanchez-Mora C., Bielsa A., et al. Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder. Biol Psychiatry 2009, 66:926-934.
55. Ribases M., Ramos-Quiroga J.A., Hervas A., Bosch R., Bielsa A., Gastaminza X., et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry 2009, 14:71-85.
56. Ribases M., Ramos-Quiroga J.A., Sanchez-Mora C., Bosch R., Richarte V., Palomar G., et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav 2011, 10:149-157.
57. Rietveld M.J., Hudziak J.J., Bartels M., van Beijsterveldt C.E., Boomsma D.I. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. JChild Psychol Psychiatry 2004, 45:577-588.
58. Salatino-Oliveira A., Genro J.P., Zeni C., Polanczyk G.V., Chazan R., Guimaraes A.P., et al. Catechol-O-methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 2012, 70:216-221.
59. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994, 265:1875-1878.
60. Saus E., Brunet A., Armengol L., Alonso P., Crespo J.M., Fernandez-Aranda F., et al. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. JPsychiatr Res 2010, 44:971-978.
61. Schizophrenia TICo Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.
62. Smoller J.W., Biederman J., Arbeitman L., Doyle A.E., Fagerness J., Perlis R.H., et al. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry 2006, 59:460-467.
63. Smoller J.W., Craddock N., Kendler K., Lee P.H., Neale B.M., Nurnberger J.I., et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.
64. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
65. Stergiakouli E., Hamshere M., Holmans P., Langley K., Zaharieva I., Hawi Z., et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 2012, 169:186-194.
66. Van Veen M.M., Kooij J.J., Boonstra A.M., Gordijn M.C., Van Someren E.J. Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia. Biol Psychiatry 2010, 67:1091-1096.
67. Voinescu B.I., Szentagotai A., David D. Sleep disturbance, circadian preference and symptoms of adult attention deficit hyperactivity disorder (ADHD). JNeural Transm 2012, 119:1195-1204.
68. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
69. Wang K., Li M., Hadley D., Liu R., Glessner J., Grant S.F., et al. PennCNV: an integrated hiddenMarkov model designed for high-resolution copy number variation detection inwhole-genome SNP genotyping data. Genome Res 2007, 17:1665-1674.
70. Williams N.M., Franke B., Mick E., Anney R.J., Freitag C.M., Gill M., et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry 2012, 169:195-204.
71. Williams N.M., Zaharieva I., Martin A., Langley K., Mantripragada K., Fossdal R., et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376:1401-1408.
72. Zhuang X., Gross C., Santarelli L., Compan V., Trillat A.C., Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999, 21:52S-60S.